title: [The antiphospholipid syndrome in 2012: its heterogeneity requires personalized care].
authors.forename: N
authors.initials: N
authors.lastname: Costedoat-Chalumeau
authors.forename: D
authors.initials: D
authors.lastname: Saadoun
authors.forename: J-C
authors.initials: JC
authors.lastname: Piette
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D017153:Antibodies, Anticardiolipin / Q000097:blood; D017152:Antibodies, Antiphospholipid / Q000097:blood*; D000925:Anticoagulants / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology / Q000276:immunology* / Q000628:therapy; D015415:Biomarkers / Q000097:blood; D005602:France / Q000453:epidemiology; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007155:Immunologic Factors / Q000097:blood*; D016682:Lupus Coagulation Inhibitor / Q000097:blood; D015995:Prevalence; D016896:Treatment Outcome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D017153:Antibodies, Anticardiolipin; D017152:Antibodies, Antiphospholipid; D000925:Anticoagulants; D015415:Biomarkers; D007074:Immunoglobulin G; D007155:Immunologic Factors; D016682:Lupus Coagulation Inhibitor